Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. scores highest on Earnings (68) and lowest on Price (7). Its PosiPenta is 38.60 out of 100, weaker than most similar companies.
On the Penta Grid this week, Tandem Diabetes Care, Inc. is Grid #585 of 837 in the Healthcare sector in United States, and Grid #3,013 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Tandem Diabetes Care, Inc. | 38.60 | 7 | 68 | 52 | 27 | 39 |
| Kardigan, Inc. | 46.53 | 29 | 35 | 38 | 68 | 63 |
| Avalyn Pharma Inc. | 38.29 | 24 | 25 | 45 | 61 | 37 |
| Syndax Pharmaceuticals, Inc. | 28.07 | 1 | 46 | 31 | 6 | 57 |
| OPKO Health, Inc. | 55.41 | 40 | 38 | 86 | 54 | 59 |
| Artivion, Inc. | 49.35 | 25 | 86 | 38 | 47 | 50 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -17.85 |
| P/B ratio | 8.67 |
EEarnings
| Trailing EPS | ₹-86.19 |
| Forward EPS | ₹15.06 |
NNitro
| Price | 1538.17 |
| 52-week high | 2808.30 |
| 52-week low | 1161.21 |
| Fall from 52-week high | 45.2% |
TTorque
| Return on equity (ROE) | -48.03% |
| Debt-to-equity | 5.67 |
AAnchor
| Beta (price swings) | 1.66 |
| Market cap | ₹10,702 Cr |
| Insider holding | 1.17% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tandem Diabetes Care, Inc.'s PosiPenta score?
Tandem Diabetes Care, Inc.'s PosiPenta is 38.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Tandem Diabetes Care, Inc. stand on the Penta Grid?
On the Penta Grid this week, Tandem Diabetes Care, Inc. is Grid #585 of 837 in the Healthcare sector in United States, and Grid #3,013 of 4,000 in United States.
Which PosiPenta pillar is strongest for Tandem Diabetes Care, Inc.?
Earnings (growth), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Tandem Diabetes Care, Inc.?
Price (valuation), with a score of 7 out of 100: much weaker than most similar companies.
Has Tandem Diabetes Care, Inc.'s PosiPenta changed since last week?
Yes, it rose 21.47 points, from 17.13 to 38.60.
PositoAI is for research and education only and is not investment advice.